What's New in JEACP-Editor-in-Chief's Insights: Highlights from the latest issue [0.03%]
JEACP主编视点：最新一期亮点抢先看
Antonio Torrelo;(JEACP Editor‐in‐Chief)
Antonio Torrelo;(JEACP Editor‐in‐Chief)
Interpreting severity in atopic dermatitis: Refining severity bands using clinical trial data [0.03%]
特应性皮炎的严重程度评估：利用临床试验数据细化严重程度分级
Luca Potestio,Maddalena Napolitano
Luca Potestio
Jorge Romaní,Joana Amat-Calbet,Francisco Russo-De la Torre et al.
Jorge Romaní et al.
Combination of advanced systemic therapy in atopic dermatitis: A multicentre observational study [0.03%]
特应性皮炎综合应用系统治疗的多中心观察研究
Marta Elosua-González,Trinidad Montero-Vilchez,Constanza Riquelme-Mc Loughlin et al.
Marta Elosua-González et al.
The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data [0.03%]
全球皮肤病负担：来自全球疾病负担的数据教训
Luigi Naldi,Simone Cazzaniga,Carsten Flohr et al.
Luigi Naldi et al.
Background: Skin diseases represent a major public health concern, affecting all demographics and imposing significant personal, economic and social burdens. ...
Clio Dessinioti,Aggeliki Befon,Mihaella Plaka et al.
Clio Dessinioti et al.
Concomitant HS and PsO: Disease severity and inflammatory phenotypes during biologic therapy [0.03%]
生物制剂治疗期间合并HS和PsO的疾病严重程度和炎症表型
Elisabetta Magnaterra,Elia Rosi,Antonella Di Cesare et al.
Elisabetta Magnaterra et al.
OX40 pathway inhibition and Kaposi sarcoma: An emerging safety signal in atopic dermatitis [0.03%]
OX40信号通路抑制与卡波西肉瘤：特应性皮炎领域的新安全问题信号
Barbara Devocht,Michiel Bonny,Erwin Suys
Barbara Devocht
Follicular phenotype of hidradenitis suppurativa in down syndrome: A multicentre case-control study [0.03%]
唐氏综合症患者汗腺炎的毛囊表型：一项多中心病例对照研究
Lucas Klepfisch,Laurie Gouillon,Janine Louise Dickinson-Blok et al.
Lucas Klepfisch et al.